Psychobiotic Supplements Market Size, Share, Industry, Forecast and outlook (2024-2031)

Psychobiotic Supplements Market is segmented By Form (Powder, Capsules, Liquid, Tablets), By Application (Food Supplements, Dietary Supplements, Infant Formula, Nutritional Supplements), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Psychobiotic Supplements Market Size

The global psychobiotic supplements market reached US$ XX million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2031. The market is growing at a CAGR of 3.72% during the forecast period (2024-2031).

Psychobiotics are a community of probiotics that impact the behaviors and related functions of the central nervous system mediated by the gut-brain axis through immune, neural, humoral, and metabolic pathways to improve gastrointestinal function, anxiolytic capacity, and the efficacy of antidepressants. The rising awareness of health and wellness drives the market for psychobiotic supplements.

Psychobiotic Supplements Market Scope

For more details on this report Request for Sample

Market Dynamics

The growing health-conscious population inclines the demand

The global standard of living is improving due to better-paying jobs that expand the middle class, which spends more on health products, including psychobiotic supplements. A rising population and greater consumer awareness of health issues, along with technological advancement and the fast-paced lives of people, are leading to changes in the lifestyle patterns of people. As a result of this upward consumer trend, numerous changes have occurred in the global psychobiotic supplements market, including research activities sponsored by probiotic manufacturers, which are positioned to fuel a healthy expansion during the projected period. For instance, in Indonesia, the middle-class population has grown from 7% to 20% of the population, with 52 million Indonesians currently belonging to the group, according to World Bank's Aspiring Indonesia-Expanding the Middle-Class report. As a result, the dietary habits of people in Indonesia have evolved toward more balanced nutrition, accompanied by a high rate of urbanization. With access to the most up-to-date information, middle-class consumers are demanding healthier and more diverse food options and health supplements, including psychobiotic supplements.

Growing consumer awareness about gut health 

The ability of psychobiotic supplements to benefit the body’s overall functions, such as digestion, is expected to drive growth. In addition, the ability of supplements to meet specific customer needs, such as immunity and gastrointestinal functions, and recent developments in product development are expected to help increase demand. In 2019, a Kerry Group survey of 2,100 health-conscious people in the U.S., as part of a global survey, found that 62% of respondents were aware of probiotics and 32% of respondents had used probiotics in the last six months. Among U.S. citizens aware of probiotics, 79 percent of respondents said that promoting good digestive health is the essential health benefit they pursue in a product. Health-conscious people in the U.S. are driving the growth of the global market for psychobiotic supplements. 

Segment Analysis

The global psychobiotic supplements market is segmented based on form, application and region.

The rising demand for traditional medication alternatives

The food supplements segment held the largest share of the global market. Psychobiotics are supplements that contain probiotics and other components to provide psychobiotic benefits, such as improved mood and better sleep. As people become more aware of their mental health, they are turning to these supplements as an alternative to traditional medications. This growing interest has led to increased demand for psychobiotic products, which the food supplement industry responds to in various ways. The food industry supports this segment's growth by introducing new products with psychobiotic ingredients. Companies are now offering foods like yogurt and cereal made with probiotics, which can easily be incorporated into a daily diet routine. These items make it easier for consumers to access these beneficial microbes without taking extra pills or supplements throughout the day. 

Source: DataM Intelligence Analysis (2023)

Geographical Penetration

The high consumption of psychobiotic supplements  due to health challenges faced by consumers in the region

North America held the largest market share in 2022. Psychobiotics are supplements containing probiotics, which are living organisms that can improve general health and well-being. This growing sector is seeing increasing demand for these products due to their potential therapeutic effects on mental health issues such as depression and anxiety and physical ailments like digestive problems. The North American psychobiotic supplements market is estimated to grow at a compound annual growth rate (CAGR) of YY% between 2023-2030. This rapid growth can be attributed to factors such as the increasing prevalence of mental disorders, rising investments in research and development for novel products, and growing consumer awareness about the benefits of psychobiotics. The key manufacturers are also launching new products, which are expected to drive market growth. For instance, On April 4, 2019, Nutra Ingredients debuted the synbiotic supplement at the Natural Products Expo West show; PlantFusion's Complete Plant Collagen Builder contains phytoceramides, psychobiotic, and amla extract. 

Source: DataM Intelligence Analysis (2023)

Competitive Landscape

The major global players include Lifted Naturals, Lallemand Health Solutions Inc., Uplift Food Pty Ltd., DuPont, BioGaia, Nature’s Bounty Co., Life Extension, Kerry Group, Bened Biomedical Co., Ltd. and NEURAXPHARM.

Key Developments

• On October 25, 2022, Taiwan's psychobiotic specialist Bened Biomedical conducted a soft launch of its first set of finished consumer products sold under the same brand name to conquer the global markets.
• On January 25, 2023, the startup Nutra Ingredients developed a next-generation psychobiotic, which took center stage at Probiota. Scientists are developing novel CRISPR engineering methods to create genome-edited probiotic bacteria strains with increased therapeutic effects on the nervous, neuroendocrine, and immune systems and enhanced metabolic processes.
• On October 13, 2020, Apsen launched Brazil's "first psychobiotic." The products contain the documented probiotic combination of Lactobacillus helveticus​ Rosell-52 and Bifidobacterium longum​ Rosell-175. Lactobacillus helveticus​ R0052 and Bifidobacterium longum​ R0175 may reduce feelings of anxiety in healthy individuals.

The global psychobiotic supplements market report would provide approximately 53 tables, 54 figures and 195 Pages